Day 2 Highlights - ESC Congress 2019

Day 2 Highlights | ESC Congress 2019
2 years 9 Views

Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss ticagrelor compared to placebo added to low-dose aspirin in patients with stale coronary artery disease (THEMIS and THEMIS-PCI—0:40); angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction and dapagliflozin and prevention of adverse outcomes in heart failure (PARAGON-HF and DAPA HF—4:08); revascularization with multivessel percutaneous coronary intervention in ST-segment elevation myocardial infarction (COMPLETE—8:17); and ticagrelor versus prasugrel in patients with acute coronary syndrome (ISAR-REACT 5—9:40). Visit for full meeting coverage.